Ocumetics completes lens exam one week postop

Executive Summary

• Ocumetics Technology Corp. has completed the one-week postoperative examination of the first patients implanted with its accommodating intraocular lens, reporting that all patients are recovering well with no observed complications.
• The company is recruiting additional individuals to complete the first group of patients for the clinical study, marking a second day of implantations following the successful initial cohort.
• The release highlights the technology's design, which utilizes the eye's natural muscular activity to focus on both distant and near objects without glasses or contact lenses, distinguishing it from traditional monofocal or multifocal lenses.

Key Details

• Clinical Status: Completed one-week postoperative examination for the first group of patients implanted with the Ocumetics accommodating intraocular lens.
• Patient Outcomes: All patients are recovering well; no complications have been observed.
• Next Steps: Additional individuals are being recruited to complete the first group of patients who will receive the lens.
• Technology Description: The lens is designed to fit within the natural lens compartment of the eye, using natural muscular activity to shift focus from distance to near, potentially eliminating the need for corrective lenses after cataract surgery.
• Development Phase: The company states it is in the preclinical study phase of this technology.

Notable Quotes

• "This is an exciting and meaningful step forward in our mission to redefine vision correction... Early outcomes with our first patients have been encouraging, allowing us to proceed with a second day of implantations." — Dean Burns, President and CEO
• "This moment culminates years of development... These first clinical results show that we are on the right path toward making that vision a reality." — Dr. Garth Webb, Chief Scientist and Founder